NCT07839234

Brief Summary

Based on PiCCO combined with MP, the optimal mechanical power setting of the ventilator for ARDS patients in normal supine/prone position is determined to reduce the damage to lung function during mechanical ventilation. By detecting peripheral serum NLRP3 and related inflammatory markers in ARDS patients, the relationship between NLRP3 and lung injury caused by mechanical ventilation was studied.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Nov 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Nov 2025Sep 2028

Study Start

First participant enrolled

November 4, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 24, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

September 24, 2026

Status Verified

September 1, 2026

Enrollment Period

2.9 years

First QC Date

August 12, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

Acute respiratory distress syndromePiCCOmechanical power

Outcome Measures

Primary Outcomes (1)

  • mechanical power

    deep sedation, elimination of spontaneous breathing, measurement via ventilator.Mechanical power (MP) was calculated from the median ventilator parameters via the following equation: mechanical power (J/min) = 0.098× RR × Vt × (PIP - 0.5(Pplateau-PEEP)), where PIP =peak inspiratory pressure. The MP was normalized to the predicted body weight (norMP) = MP/PBW,where PBW was the predicted body weight measured in kilograms.

    Data were obtained within the first hour post-intubation, at 8:00 AM (±1 h) daily for the subsequent three consecutive days, and during position changes (prone to supine or supine to prone) within these three days.

Study Arms (2)

Prone ventilation group

non-Prone ventilation group

Other: Prone position ventilation

non-Prone ventilation group

non-Prone ventilation

Interventions

Judgement of Prone Position Therapy Based on Oxygenation Index

Prone ventilation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The research plan includes 130 patients. Divide into two groups, with 65 cases in each group. A: ARDS patients who use conventional ventilation during mechanical ventilation; B: ARDS patients who use prone position ventilation during mechanical ventilation.

You may qualify if:

  • Admission to ICU
  • Accept mechanical ventilation, with an expected duration of more than 3 days
  • Diagnose 'ARDS' and meet the criteria for mild, moderate, and severe diagnosis
  • Age over 18 years old
  • Voluntarily participate in the study and sign an informed consent form (if the patient has consciousness disorders, it can be signed by a legal representative)

You may not qualify if:

  • There are contraindications for PiCCO monitoring
  • Pregnant or lactating women
  • Recently (within one month) participated in other interventional clinical studies
  • Expected death within 48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiamen Hospital of Traditional Chinese Medicine

Xiamen, Fujian, 361009, China

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

August 12, 2026

First Posted

September 24, 2026

Study Start

November 4, 2025

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

September 24, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

No raw individual-level participant data will be publicly shared. Upon reasonable scientific request and after signing a data-use agreement, de-identified aggregated clinical data may be provided. No identifiable personal information including names, ID numbers, addresses or contact information will be released.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
The IPD and supporting information will be available starting from 1 December 2028 to 31 December 2029.
Access Criteria
Access is limited to qualified non-commercial academic researchers. Approved users can obtain anonymized IPD and full trial supporting documents including analysis reports. Applicants shall submit a research application for committee review first, and then get secure platform access upon approval.
More information

Locations